University of Illinois Cancer Center — Chicago, Illinois

University of Illinois Cancer Center is a clinical research site located in Chicago, Illinois, United States 60612-7243.

Crixeo Health Trust Score: 89/100 (GOOD). This profile has not yet been claimed by the site owner.

University of Illinois Cancer Center has participated in 122 clinical trials with 38 currently active.

Therapeutic areas: Lymphoma, Kidney Cancer, Endometrial Adenocarcinoma.

Sponsors: Alliance for Clinical Trials in Oncology, Eastern Cooperative Oncology Group, Acrivon Therapeutics.

Sponsor Feasibility Report

Trust Score: 89/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Illinois Cancer Center?

University of Illinois Cancer Center has a Crixeo Trust Score of 89/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Illinois Cancer Center conducted?

University of Illinois Cancer Center has 122 clinical trials on record, with 38 currently active. Their work covers Lymphoma, Kidney Cancer, Endometrial Adenocarcinoma.

Is University of Illinois Cancer Center accredited by Crixeo Health?

Yes — University of Illinois Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about University of Illinois Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.